LifeSci Capital

Overview

LifeSci Capital is a research-driven investment bank specializing exclusively in the life sciences sector. The firm offers a comprehensive suite of services, including equity research, investment banking, and equity capital markets, all tailored to meet the unique needs of emerging life science and healthcare companies. Their team is dedicated to providing high-quality, expert-driven equity research that engages investors and fosters shareholder conversion. The firm's investment banking division provides thoughtful, actionable advice related to corporate finance strategy, mergers and acquisitions advisory, and equity and debt capital markets. Their seasoned professionals leverage close relationships with investors to offer insights into investor sentiment, ensuring that clients receive informed and strategic guidance. LifeSci Capital's equity capital markets activities are designed to raise the visibility of covered companies and educate investors on compelling opportunities, further enhancing their clients' market presence. LifeSci Capital's commitment to the life sciences sector is evident in their specialized focus and the depth of their expertise. Their research products, such as the Alpha Series and KOL Series, offer differentiated insights into therapeutic indications, providing the investment community with a deep understanding of the companies within and beyond their coverage universe. This dedication to high-conviction research and investor engagement underscores their position as a premier banking partner in healthcare finance.

Investment Focus

• Companies must be in the life sciences or healthcare sectors
• Companies should be emerging or in early to growth stages
• Companies should be seeking equity or debt financing
• Companies should be open to strategic advisory services
• Companies should be based in the United States

Portfolio Companies